Chronokines
Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers
Emilie Branch; Frank D. Lee
Pharma's Almanac
PAP-Q2-20-CL-003Jul 01, 2020
Collaboration
FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors
Forma Therapeutics
PR-M05-18-NI-051May 14, 2018